InvestorsHub Logo
Followers 53
Posts 3433
Boards Moderated 0
Alias Born 10/26/2013

Re: hyperopia post# 599454

Thursday, 06/08/2023 9:45:24 AM

Thursday, June 08, 2023 9:45:24 AM

Post# of 705331
OK, after reviewing the Guideline again (and not racing thru it), I see the first bullet in the Background section is relevant

The nonclinical information described above addresses critical issues that allow the Agency to,
59 for example:
60
61 • Identify the pharmacological effects, including mechanism(s) of action of the drug in
62 vitro and/or in vivo

Good stuff.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News